Korean J Med.  2013 Sep;85(3):256-259. 10.3904/kjm.2013.85.3.256.

Updates of Spondyloarthrothy Treatment

Affiliations
  • 1Department of Rheumatology, Hanyang University Hospital for Rheumatic Disease, Seoul, Korea. thkim@hanyang.ac.kr

Abstract

The goals of treatment in Spondyloarthropathy are to reduce pain and stiffness, and to maintain good quality of life. Regular exercise with stretching of axial skeleton is most important. No drugs have been prevented ankylosis, but non steroidal anti inflammatory drugs (NSAIDs) are the first line drugs and these are very effective in most of patients who have inflammatory back pain. In recent years, reports that long-term use of NSAIDs may reduce the ankylosis are coming out and expect NSAIDs as anti ankylosis drugs. If NSAIDs is not effective, anti TNF agents can be used in severe inflammatory back pain. In peripheral arthritis, sulfasalazine or steoids can be used, and If these are failed, anti TNF agents can be used.

Keyword

Spondyloarthropathy; NSAIDs; Anti TNF

MeSH Terms

Ankylosis
Anti-Inflammatory Agents, Non-Steroidal
Arthritis
Back Pain
Humans
Quality of Life
Skeleton
Spondylarthropathies
Steroids
Sulfasalazine
Anti-Inflammatory Agents, Non-Steroidal
Steroids
Sulfasalazine
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr